McMaster University researchers have identified why certain patients develop dangerous blood clots after exposure to common blood thinners, offering potential prevention strategies. This breakthrough addresses a serious complication that can occur in patients requiring anticoagulation therapy. Understanding the underlying mechanism could lead to improved treatment protocols and safer medication use. The findings are particularly important for patients with heart disease, stroke prevention, and those undergoing surgery who rely on blood thinners for protection.
